Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice

Diabetes

Volumn 48, Issue 3, 1999, Pages 469-477

  Liu, Junliang ^a   Purdy, Lisa E ^a   Rabinovitch, Simon ^a   Jevnikar, Anthony M ^b,c   Elliott, John F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; DIABETES MELLITUS; DISEASE PREDISPOSITION; EPITOPE MAPPING; GENE LOCATION; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0033048174     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.3.469     Document Type: Article

References (55)

1. Castano L, Eisenbarth GS: Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647-679, 1990
2. Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup Poulsen T, de Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, Sundquist G, Lernmark Å: Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79:926-934, 1987
3. Harrison LC, Honeyman MC, Deaizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation between humoral and cellular immunity to glutamate acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
4. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu D, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458-159, 1992
5. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 94:2125-2129, 1994
6. Kaufman DL, Clare-Salzler M, Tian J, Forstuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
7. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-75, 1993
8. 67) prevents autoimmune diabetes in NOD mice. Diabetes 43:1494-1499, 1994
9. Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183:1561-1567, 1996
10. Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman, D, Mueller R, Arita S, Evans C, Atkinson MA, Mullen Y, Sarvetnick N, Tobin AJ, Lehmann PV, Kaufman DL: Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 2:1348-1353, 1996
11. Ma SW, Zhao DL, Yin ZQ, Mukherjee R, Singh B, Qin HY, Stiller CR, Jevnikar AM: Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 3:793-796, 1997
12. Petersen JS, Russel S, Marshall MO, Kofod H, Buschard K, Cambon N, Karlsen AE, Boel E, Hagopian WA, Hejnaes KR, Moody A, Dyberg T, Lernmark A, Madsen OD, Michelsen BK: Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42:484-495, 1993
13. 67 in pancreatic islets of man, rat, and mouse. Diabetes 42:1799-1808, 1993
14. Todd JA, Bell JI, McDevitt HO: HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1987
15. Thorsby E, Ronnigen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type I (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377, 1993
16. Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffith RL: HLA-DQb sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39:96-103, 1990
17. Penny MA, Mijovic CH, Cavan DA, Jacobs KH, Jenkins D, Fletcher J, Barnett AH: An investigation of the association between HLA-DQ heterodimers and type I (insulin-dependent) diabetes mellitus in five racial groups. Hum Immunol 38:179-183, 1993
18. Law YM, Yeung RS, Mamalaki C, Kioussis D, Mak TW, Flavell RA: Human CD4 restores normal T cell development and function in mice deficient in murine CD4. J Exp Med 179:1233-1242, 1994.
19. Okada K, Boss JM, Prentice H, Spies T, Mengler R, Auffray C, Lillie J, Groosberger D, Strominger JL: Gene organization of DC and DX subregions of the human major histocompatibility complex. Proc Natl Acad Sci U S A 82:3410-3414, 1985
20. Anderson CC, Mukherjee R, Sinclair NR, Jevnikar AM: Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules. Clin Exp Immunol 109:473-479, 1997
21. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417-1420, 1991
22. Hogan B, Costantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY Cold Spring Harbor Press, 1986
23. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY, Cold Spring Harbor Press, 1989
24. Harlow E, Lane D: Antibodies: A Laboratory Manual. Cold Spring Harbor, NT, Cold Spring Harbor Press, 1988
25. Holte H, Blomhoff HK, Beiske K, Funderud S, Torjesen P, Gaudernack G, Stokke T, Smeland EB: Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens. Eur J Immunol 19:1221-1225, 1989
26. Spits H, Borst J, Giphart M, Coligan J, Terhorst C, de Vries JE: HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur J Immunol 14:299-304, 1984
27. Elliott JF, Albrecht GR, Gilladoga A, Handunnetti SM, Neequaye J, Lallinger G. Minjas JN, Howard RJ: Genes Plasmodium falciparum surface antigens cloned by expression in COS cells. Proc Natl Acad Sci U S A 87:6363-6367, 1990
28. Mertens N, Remaut E, Fiers W: Tight transcriptional control mechanism ensures stable high-level expression from T7 promoter-based expression plasmids. Biotechnology (N Y) 13:175-179, 1995
29. Wicker LS, Chen S-L, Nepom GT, Elliott JF, Freed DC, Bansal A, Zheng S, Herman A, Lernmark A, Zaller DM, Peterson LB, Rothbard JB, Cummings R, Whiteley PJ: Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type I diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 98:2597-2603, 1996
30. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CCA: TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78-83, 1998
31. Ichikawa M, Johns TG, Liu J, Bernard CC: Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 157:919-926, 1996
32. Chicz RM, Lane WS, Robinson RA, Trucco M, Strominger JL, Gorga JC: Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int Immunol 6:1639-1640, 1994
33. Godkin A, Friede T, Davenport M, Stevanovic S, Willis A, Jewell D, Hill A, Rammensee HG: Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int Immunol 9:905-911, 1997
34. Kwok WW, Domeier ME, Raymond FC, Byers P, Nepom GT: Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol 156:2171-2177, 1996
35. Gedde-Dahl T III, Spurkland A, Eriksen JA, Thorsby E, Gaudernack G: Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-Leu61). Int Immunol 4:1331-1337, 1992
36. Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS: HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 183:27-37, 1996
37. Cheng S, Baisch J, Krco C, Savarirayan S, Hanson J, Hodgson K, Smart M, David C: Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in transgenic mice. Eur J Immunogenet 23:15-20, 1996
38. Zanelli E, Krco CJ, Baisch JM, Cheng S, David CS: Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci U S A 93:1814-1819, 1996
39. Zanelli E, Krco CJ, David CS: Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J Immunol 158:3545-3551, 1997
40. Neeno T, Krco CJ, Harders J, Baisch J, ChengS, David CS HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens: identification of antigenic epitopes. J Immunol 156:3191-3195, 1996
41. Raju R, Munn SR, David CS: T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQS and DQ6 transgenic mice. Hum Immunol 58:21-29, 1997
42. Kong YM, David CS, Lomo LC, Fuller BE, Motte RW, Giraldo AA: Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 46:312-317, 1997
43. Raju, R, Zhan WZ, Karachunski P, Conti-Fine B, Sieck GC, David C: Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis. J Immunol 160:4169-4174, 1998
44. g7 in non-obese diabetic mice. Immunogenetics 46:29-34, 1997
45. Zechel MA, Elliott JF, Atkinson MA, and Singh B: Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J Autoimmun 11:83-95, 1998
46. Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler A-G, Wank R, Schendel DJ: Identification of naturally processed T cell epitopes from glutamic add decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 99:2405-2415, 1997
47. Lohmann T, Leslie RD, Londei M: T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J Autoimmun 9:385-389, 1996
48. Patel SD, Cope AP, Congia M, Chen TT, Kim E, Fugger L, Wherrett D, Sonderstrup-McDevitt G: Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(A1*0101,B1*0401) transgenic mice. Proc Natl Acad Sci U S A 94:8082-8087, 1997.
49. Fugger L, Liang J, Gautam A, Rothbard JB, McDevitt HO: Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis. Mol Med 2:181-188, 1996
50. Bernard CCA, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J: Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75:77-88, 1997
51. Bellone M, Karachunski PI, Ostlie N, Lei S, Conti-Tronconi BM: Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes. Eur J Immunol 24:799-804, 1994
52. Reizis B, Altmann DM, Cohen IR: Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice. Eur J Immunol 27:2478-2483, 1997
53. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM: Gliadin-specific, HLA-DQ(alpha 1*0.501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178:187-196, 1993
54. Gjertsen HA, Sollid LM, Ek J, Thorsby E, Lundin KE: T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol 39:567-574, 1994
55. McMichael AJ, O'Callaghan CA: A new look at T cells. J Exp Med 187:1367-1371, 1998